streptococcu
equi
subspeci
equi
caus
agent
strangl
highli
contagi
upper
respiratori
tract
infect
hors
typic
clinic
sign
diseas
includ
fever
inappet
lethargi
submandibular
retropharyng
lymphadenopathi
purul
drainag
purul
nasal
discharg
complic
equi
infect
occur
includ
airway
obstruct
lymphadenopathi
dissemin
abscess
hematogen
spread
purpura
hemorrhagica
variou
diseas
caus
streptococcu
equi
protein
sem
antibodi
titer
typic
measur
determin
hors
develop
complic
strangl
purpura
hemorrhagica
metastat
abscess
format
determin
hors
risk
purpura
hemorrhagica
vaccin
american
colleg
veterinari
intern
medicin
consensu
statement
strangl
state
high
titer
associ
metastat
abscess
format
purpura
hemorrhagica
high
titer
detect
week
anecdot
hors
high
titer
week
infect
sign
complic
author
person
observ
kmd
lab
act
object
studi
measur
sem
antibodi
titer
hors
outbreak
determin
titer
detect
presenc
addit
object
follow
sem
antibodi
titer
month
infect
determin
immunoglobulin
decay
monitor
develop
addit
complic
hypothes
magnitud
sem
antibodi
titer
infect
sem
titer
use
monitor
presenc
complic
risk
develop
complic
clinic
observ
studi
convalesc
sem
antibodi
titer
strangl
outbreak
high
rate
complic
sampl
obtain
inform
client
consent
approxim
week
initi
diagnosi
infect
equi
serum
collect
via
jugular
venipunctur
hors
farm
equi
protein
antibodi
titer
measur
via
elisa
hors
equin
diagnost
solut
llc
lexington
ky
week
initi
diagnosi
serum
collect
repeat
sem
antibodi
titer
select
hors
n
week
initi
diagnosi
serum
collect
measur
sem
antibodi
titer
n
physic
examin
perform
time
point
determin
hors
display
sign
diseas
data
hors
properti
collect
initi
diagnosi
remov
quarantin
data
collect
includ
signal
clinic
sign
display
absenc
clinic
sign
nasopharyng
lavag
guttur
pouch
gp
endoscopi
lavag
result
equi
cultur
polymeras
chain
reaction
pcr
evid
complic
vaccin
statu
surviv
affect
hors
categor
accord
clinic
sign
diseas
categori
diseas
uncompl
case
persist
gp
infect
complic
case
diseas
defin
clinic
evid
equi
infect
uncompl
case
defin
clinic
sign
fever
inappet
purul
nasal
discharg
submandibular
retropharyng
lymphadenopathi
drainag
persist
gp
infect
defin
gp
infect
posit
nasopharyng
gp
lavag
equi
cultur
pcr
last
complic
case
strangl
defin
sequela
atyp
case
includ
sign
purpura
hemorrhagica
metastat
abscess
format
abscess
remot
lymph
node
head
secondari
infect
dysphagia
hors
evid
persist
gp
infect
complic
categor
dualli
hors
uncompl
strangl
persist
gp
infect
frequenc
titer
differ
diseas
categori
determin
median
sem
antibodi
titer
categori
well
vaccin
statu
determin
test
use
analyz
differ
titer
level
vaccin
statu
correl
diseas
categori
sem
antibodi
titer
level
analyz
pearson
test
sensit
specif
ci
confid
interv
sem
antibodi
titer
detect
complic
persist
gp
infect
calcul
mean
reciproc
antibodi
titer
time
point
calcul
regress
calcul
determin
antibodi
decay
time
valu
p
consid
statist
signific
equi
outbreak
board
facil
began
late
januari
last
approxim
month
equi
detect
farm
hors
develop
sign
colic
lethargi
fever
hors
isol
veterinari
hospit
fecal
pcr
test
perform
hors
posit
equin
coronaviru
hors
diagnos
hors
note
lethargi
fever
occasion
colic
sign
fifteen
hors
presum
initi
infect
coronaviru
base
clinic
sign
fecal
pcr
test
perform
addit
case
howev
neg
equin
coronaviru
approxim
week
later
hors
note
submandibular
lymphadenopathi
confirm
equi
infect
quarantin
affect
hors
attempt
howev
cours
outbreak
hors
hous
area
clinic
sign
movement
properti
stop
hors
properti
equi
outbreak
age
rang
year
mean
year
breed
includ
quarter
hors
qh
n
tennesse
walk
hors
twh
n
arabian
n
paint
n
thoroughbr
n
warmblood
n
morgan
n
breed
n
thirteen
femal
castrat
male
hors
develop
clinic
sign
consist
strangl
affect
hors
age
rang
year
mean
year
breed
includ
qh
n
paint
n
twh
n
arabian
n
warmblood
n
morgan
n
breed
n
seven
femal
castrat
male
signal
affect
hors
similar
whole
expos
popul
eight
hors
histori
previou
vaccin
equi
five
vaccin
hors
develop
clinic
sign
diseas
develop
clinic
sign
week
initi
detect
equi
new
hors
develop
clinic
sign
clinic
sign
affect
hors
resolv
test
detect
persist
gp
infect
perform
week
initi
infect
conjunct
measur
sem
antibodi
titer
hors
test
persist
gp
infect
via
either
nasopharyng
lavag
n
gp
endoscopi
lavag
n
equi
pcr
cultur
decis
perform
nasopharyng
lavag
gp
endoscopi
base
attend
veterinarian
recommend
client
prefer
thirteen
hors
test
persist
gp
infect
statu
base
owner
declin
test
twelv
hors
categor
sign
diseas
categor
uncompl
case
strangl
hors
affect
uncompl
strangl
persist
gp
infect
complic
case
persist
gp
infect
complic
hors
persist
gp
infect
endoscop
visibl
chondroid
complic
case
purpura
hemorrhagica
metastat
abscess
format
secondari
pleuropneumonia
dysphagia
mean
age
similar
diseas
categori
vaccin
hors
develop
clinic
sign
uncompl
strangl
persist
gp
infect
persist
gp
infect
complic
affect
hors
surviv
long
term
month
infect
wherea
euthan
hors
euthan
complic
case
includ
metastat
abscess
format
infarct
purpura
hemorrhagica
secondari
pleuropneumonia
dysphagia
streptococcu
equi
subspeci
equi
antibodi
titer
hors
week
infect
shown
figur
one
titer
titer
titer
titer
titer
titer
titer
mean
age
similar
sem
antibodi
titer
figur
show
distribut
sem
antibodi
titer
hors
without
clinic
sign
equi
infect
median
sem
antibodi
titer
hors
without
clinic
sign
respect
correl
hors
clinic
sign
sem
antibodi
titer
pearson
r
p
note
equi
protein
antibodi
titer
affect
hors
compar
specif
clinic
syndrom
figur
median
sem
antibodi
titer
uncompl
case
persist
gp
infect
complic
case
correl
hors
persist
gp
infect
complic
case
sem
antibodi
titer
pearson
r
p
pearson
r
p
respect
also
found
six
hors
high
sem
antibodi
titer
evid
complic
case
figur
equi
protein
antibodi
titer
nonsurvivor
n
outbreak
sensit
specif
sem
antibodi
titer
detect
complic
ci
ci
respect
use
cutoff
instead
sensit
specif
detect
complic
ci
ci
respect
hors
persist
gp
infect
sem
antibodi
titer
sem
antibodi
titer
sensit
specif
sem
antibodi
titer
detect
persist
gp
infect
ci
ci
respect
use
cutoff
instead
sensit
specif
detect
persist
gp
infect
ci
ci
respect
vaccin
hors
titer
titer
titer
titer
titer
median
titer
vaccin
hors
compar
unvaccin
hors
significantli
differ
p
week
infect
sem
antibodi
titer
measur
hors
previou
titer
hors
n
n
n
n
n
week
time
point
titer
titer
titer
titer
figur
one
hors
titer
treat
metastat
abscess
format
second
hors
titer
persist
gp
infect
evid
complic
third
hors
titer
clinic
evid
diseas
complic
two
hors
week
infect
persist
gp
infect
sem
antibodi
titer
fifteen
hors
time
point
decreas
sem
antibodi
titer
week
infect
sem
antibodi
titer
measur
hors
includ
hors
still
properti
area
eight
hors
lost
euthan
secondari
equi
infect
week
time
point
titer
titer
titer
titer
titer
titer
figur
hors
time
point
evid
clinic
diseas
thirti
hors
demonstr
declin
sem
antibodi
titer
declin
r
p
mean
sem
reciproc
antibodi
titer
time
point
rang
week
infect
rang
week
infect
rang
week
infect
figur
percent
hors
outbreak
sem
antibodi
titer
eight
week
infect
contrast
typic
outbreak
previou
sem
antibodi
titer
recent
studi
measur
sem
antibodi
titer
month
natur
month
infect
none
hors
test
sem
antibodi
titer
sem
antibodi
titer
occur
experiment
commingl
sem
antibodi
titer
peak
week
experiment
infect
igga
titer
rise
iggb
titer
rise
experiment
studi
describ
hors
develop
complic
outbreak
hors
complic
sem
antibodi
titer
complic
case
sem
antibodi
titer
one
case
dysphagia
caus
sever
gp
diseas
later
euthan
case
mild
sign
purpura
hemorrhagica
resolv
without
use
immunosuppress
medic
case
illustr
sem
antibodi
titer
infect
might
follow
typic
interpret
titer
support
diagnosi
metastat
abscess
format
purpura
howev
increas
titer
would
warrant
diagnost
rule
equi
complic
hors
outbreak
sem
antibodi
titer
week
infect
uncompl
case
persist
gp
infect
complic
case
persist
gp
infect
complic
case
figur
base
data
calcul
sensit
specif
sem
antibodi
titer
might
use
monitor
complic
risk
complic
outbreak
high
sensit
necessarili
confirm
complic
present
low
specif
equi
protein
antibodi
titer
correl
persist
gp
outbreak
hors
persist
gp
infect
week
infect
hors
sem
antibodi
titer
sem
antibodi
titer
high
sem
antibodi
titer
hors
like
relat
continu
exposur
organ
elicit
immun
respons
sem
antibodi
titer
sensit
specif
detect
persist
gp
infect
low
respect
howev
use
cutoff
sensit
specif
unaccept
correl
applic
popul
outbreak
determin
base
outbreak
increas
sem
antibodi
titer
outbreak
could
warrant
addit
diagnost
includ
test
carrier
statu
via
nasopharyng
gp
lavag
report
outbreak
novel
high
proport
hors
sem
antibodi
titer
also
high
proport
hors
complic
diseas
compar
report
complic
rate
outbreak
case
fatal
complic
case
high
compar
report
case
fatal
complic
case
lastli
high
proport
hors
develop
persist
gp
infect
higher
previou
report
consist
recent
report
possibl
explan
higher
complic
rate
higher
convalesc
sem
antibodi
titer
includ
higher
dose
exposur
virul
equi
popul
caus
equi
organ
sequenc
protein
gene
outbreak
role
possibl
concurr
equin
enter
coronaviru
infect
contribut
high
complic
rate
outbreak
unknown
could
result
delay
detect
quarantin
specif
equi
transmiss
could
result
immunosuppress
allow
sequela
repeat
sem
antibodi
titer
reveal
immunolog
decay
case
time
point
consist
resolut
diseas
discontinu
exposur
organ
consist
previou
report
experiment
late
week
infect
hors
sem
antibodi
titer
one
hors
treat
metastat
abscess
format
titer
declin
consist
respons
treatment
week
infect
hors
sem
antibodi
titer
similar
recent
outbreak
report
hors
sem
antibodi
titer
outbreak
serolog
test
perform
month
high
titer
persist
hors
week
infect
would
previous
interpret
consist
week
declin
persist
increas
serum
iggb
titer
level
previous
report
week
experiment
limit
interpret
data
outbreak
exact
date
infect
time
resolut
clinic
sign
hors
unknown
sem
antibodi
titer
unknown
outbreak
peak
sem
antibodi
titer
could
detect
sem
antibodi
titer
peak
week
experiment
serolog
test
test
carrier
statu
perform
week
initi
infect
report
addit
select
bia
like
exist
week
infect
time
point
major
hors
recheck
previou
titer
lastli
hors
test
carrier
statu
presum
persist
gp
infect
howev
could
led
misclassif
initi
test
carrier
statu
hors
test
nasopharyng
lavag
larg
base
econom
howev
current
recommend
detect
carrier
statu
endoscopi
gp
limit
could
led
underestim
number
hors
persist
gp
infect
outbreak
could
also
led
overestim
sensit
specif
sem
antibodi
titer
detect
persist
gp
infect
hors
sem
antibodi
titer
howev
outbreak
studi
indic
sem
titer
use
outbreak
illustr
util
sem
antibodi
titer
infect
equi
studi
demonstr
hors
may
complic
strangl
without
sem
antibodi
titer
hors
may
sem
antibodi
titer
without
complic
convalesc
sem
antibodi
titer
warrant
addit
investig
complic
persist
gp
infect
necessarili
confirm
hors
complic
diseas
antimicrobi
use
dr
john
timoney
share
patent
sem
sequenc
us
patent
octob
dr
jennif
morrow
equin
diagnost
solut
llc
lexington
ky
sampl
analysi
sem
antibodi
titer
elisa
perform
author
declar
iacuc
approv
need
inform
client
consent
obtain
author
declar
human
ethic
approv
need
studi
